Webinar: New PMPRB Guidelines – Impact on Drug Pricing in Canada

Webinar: New PMPRB Guidelines – Impact on Drug Pricing in Canada

Wednesday, November 25 – 5:00 pm -6:00 pm EST

Topic: Final Patented Medicine Prices Review Board Guidelines were published earlier this Fall.  These Guidelines and the Patent Medicine Regulations they interpret, represent the biggest change to the regulation of Canadian drug prices in thirty years.   The Regulations mandate consideration of health economics as a factor in determining the allowable price for new medicines, and mandate interaction between CADTH and PMPRB.  The Director of Pricing and Market Access from PDCI Market Access will provide an update on how the changes will impact new drugs, and the implications for the regulatory approval process.   

 Registration Deadline: Monday, November 23, 2020 
*Registrants may be substituted, but no refunds will be issued after the deadline. 
*Disclaimer: CAPRA reserves the right to make amendments to the conference (including but not limited to speakers' identity, topics, locations, the timing of speakers) without notice to you. If the conference is canceled for any reason whatsoever, such reason not within the control of CAPRA, CAPRA shall not be liable for any cost or loss otherwise incurred.

Event Registration Form: Please add your First name, Last name and the Email address that you will use to log in the day of the webinar. 
Be sure to check system requirements to avoid any connection issues the day of the event. 
In case of unexpected interruptions such as a power outage please log back, and the webinar will restart  from where it was disconnected.

Speakers / Panelists

Registration is now closed